Press Release
September 20, 2017
Amphastar Pharmaceuticals Receives FDA Approval for Sodium Bicarbonate Injection
More
August 30, 2017
Amphastar Pharmaceuticals to Present at the 2017 Wells Fargo Securities Healthcare Conference
More
August 9, 2017
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017
More
August 2, 2017
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9, 2017
More
July 24, 2017
Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.
More
June 1, 2017
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
More
May 10, 2017
Amphastar Pharmaceuticals to Present at the 20th Annual Bank of America Merrill Lynch Health Care Conference
More
May 8, 2017
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017
More
May 4, 2017
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on May 8, 2017
More
March 31, 2017